Literature DB >> 2938974

Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in BALB.B.

S Sadegh-Nasseri, V Dessi, E E Sercarz.   

Abstract

Immune responsiveness to lysozyme in H-2b mice is under the control of H-2-linked Ir genes, with T suppressor (Ts) cells playing a dominant role in strains such as C57BL/6 (B6), C57BL/10 and A.BY. However, non-H-2-genes were found to be capable of specific reversal of the effect of the H-2-linked genes in responsiveness to chicken lysozyme (HEL), but not to human lysozyme (HUL). Therefore, studies were performed to identify any lesion in the suppressor circuit in BALB.B. It was known that HUL-induced suppressor cells could cross-suppress the anti-HEL response in B10.Q mice, which are responsive to HEL but nonresponsive to HUL. Similarly, BALB.B Ts cells were able to suppress the anti-HEL response, using as T helper (Th) source a T cell line (BB-1), derived from HEL-primed BALB.B periaortic and inguinal lymph node cells. A protocol designed to examine the in vivo suppression by the use of HUL-induced suppressor cells also demonstrated a significant suppression of the anti-HEL response. Since the suppressive circuitry seemed intact in the BALB.B, the possibility was examined that a step in T-B cell collaboration was more efficient in this strain than in the B6 nonresponder. With a B6-derived HEL-specific T cell line, BO1H, the B cell and antigen-presenting (B/APC) populations from B6 required addition of concanavalin A supernatant for anti-HEL antibody formation, whereas BALB.B B/APC were capable of responding to HEL in culture without the addition of concanavalin A supernatant. In agreement with this finding, when B/APC cell populations from BALB.B and B6 were compared for their extent of anti-HEL responsiveness, as measured with BB-1 Th cells, BALB.B B/APC populations responded significantly higher than B6 populations when the responses were activated by picogram/nanogram amounts of HEL. The response level of (BALB.B X B6)F1 B/APC measured in the same assay resembled that of B6. However, when HEL was used at the microgram level, both B6 and BALB.B strains responded equivalently. The above data are consistent with the expression of the reversing non-H-2 Ir gene(s) resulting from the balance of antigen presentation to Th and Ts cells in the H-2b mouse. In the B6, processing and handling of antigen may be inefficient in activating response-enhancing Th, and more effective in triggering Ts cells, while the reverse may be true for the BALB.B.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938974     DOI: 10.1002/eji.1830160504

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin.

Authors:  A M Mowat; A G Lamont; D M Parrott
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

3.  Immune suppression genes control the anti-F antigen response in F1 hybrids and recombinant inbred sets of mice.

Authors:  D B Oliveira; N B Nardi
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Interferon-gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation.

Authors:  G P Holland; N Holland; M W Steward
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  The functional link between the immune suppression gene and Mhc class II molecules.

Authors:  K Mizuno; S Tsuchimoto; Y Matsuno; T Niiyama; H Fujii; T Natori; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.